One Drop received nearly $100 million in financing and payments from Bayer

, 's leader in digital solutions for people with diabetes and other chronic diseases, recently announced that it has reached a new agreement with Bayer to develop digital health products for multiple therapeutic areas based on One Drop's predictive, preventive and personalized self-care platform. The company has completed a $34.7 million round C financing led by Bayer and will receive $64 million in development costs and potential business milestone payments.this new agreement demonstrates Bayer's commitment to working with One Drop and supporting One Drop's vision for the future of chronic disease management: data-driven, efficient and personalized self-care. One Drop's successful solution is data-driven, its app has been downloaded more than 3 million times, and the company collects more than 13 billion different health data points from users who download it. This data-driven platform delivers a user-centric experience and appropriate interventions at the right time to achieve health forecasting.currently supports patients in managing diabetes, pre-diabetes, high blood pressure, and high cholesterol. Bayer's $64 million development costs and potential business milestone payments will help One Drop's industry-leading solutions expand into Bayer's focus areas such as heart disease, oncology and women's health. The modular structure of One Drop solutions will help the company expand into new therapeutic areas. One Drop's self-care experience will support all diseases that individuals may need to address, rather than treating individual diseases, providing a comprehensive approach to driving sustainable outcomes.Jeff Dachis, chief executive and founder of One Drop, said: "To achieve better health outcomes and lower costs at the patient level, we must focus on individuals. One Drop provides personalized health transformation solutions that adapt to each user's needs and daily behavior to support the best health outcomes for each user. By contrast, other platforms that don't have a massive data and prediction engine like ours still focus on telemedicme and telemedicus, responding to problems that have already occurred, and providing a common model for some users, but for most people, it's useless.Since 2016, One Drop's digital health platform has been available to consumers, employers, insurance companies and healthcare providers, and its effectiveness has been confirmed by more than 20 peer-reviewed studies that have significantly improved blood sugar control in diabetics in just one month. Recently, at the 80th annual meeting of the American Diabetes Association, One Drop presented long-term glycation hemoglobin, blood pressure and weight outcome predictions for people with diabetes, hypertension and pre-diabetes, as well as nighttime hypoglycemia predictions for continuous blood glucose monitor (CGM) users. These predictions are based on the same demographic data that supports the machine learning model behind One Drop's health forecasts and insights. Currently, One Drop users receive eight hours of blood sugar prediction and real-time advice on exercise, diet and lifestyle changes each time they record data in the One Drop app.Jeanne Kehren, Head of Digital and Business Innovation at Bayer and a member of the Pharmaceutical Executive Committee, said, "Building a new digital business model is an important part of our business strategy and we want to be actively involved in the future of healthcare. We believe that a data-driven approach can help patients achieve better results for themselves and re-focus patients, not disease. The new partnership with One Drop will enable Bayer to further accelerate the growth of its digital health business and lay the foundation for a new comprehensive patient care service product. One Drop's intelligent solutions focus on individual users and address the "last mile" between healthcare and self-care by meeting the needs of industry stakeholders, from service providers who want to improve patient care, manufacturers who want to maximize efficiency, to users looking for better results and lower healthcare costs.One Drop Introduction One Drop leverages the power of clinical science, behavioral science, and advanced artificial intelligence to improve the lives of chronically ill people around the world and reshape possibilities. One Drop's evidence-based digital health platform is clinically proven to be effective, providing one-on-one guidance and personalized health transformation programs that promote positive behavioral change and better outcomes for all individuals, while reducing costs for insurers, employers, and healthcare providers. One Drop's products and services can be purchased through One Drop's award-winning apps (iOS and Android) as well as Wal-Mart, Amazon, BestBuy, Apple Store and CVS.For more information on how to help your organization reduce the cost of care, please contact results@onedrop.todayBayer Profile Bayer is a global company with core health and nutrition competencies in the life sciences. Through its products and services, the company is committed to helping people overcome the major challenges posed by the growing and ageing global population for the benefit of humanity. At the same time, Bayer is increasing profitability and creating value through technological innovation and business growth. Bayer is committed to sustainable development. Globally, the Bayer brand stands for credibility, reliability and quality. In fiscal 2019, Bayer employs approximately 104,000 people, with sales of EUR 43.5 billion, capital expenditure of EUR 2.9 billion and research and development investment of EUR 5.3 billion. (U.S. News Agency)